Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 3, 2010, Pages 911-916

  Brazzelli, Valeria ^a   Grasso, V ^a   Fornara, L ^a   Moggio, E ^a   Gamba, G ^a   Villani, S ^a   Borroni, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Folic acid; Homocysteine; Psoriasis; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; DISEASE SEVERITY; ERYTHEMATOSQUAMOUS SKIN DISEASE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; RISK FACTOR; VITAMIN BLOOD LEVEL; BLOOD; MIDDLE AGED; PATHOLOGY; PSORIASIS; RETROSPECTIVE STUDY; SKIN;

FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN; VITAMIN B 12;

EID: 78149257221     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300327     Document Type: Article

References (23)

1. Lebwohl M. Psoriasis. Lancet 2003; 361:1197-204.
2. 12 and folic acid levels in psoriasis patients. J Eur Acad Dermatol Venereol 2009; 23:300-303.
3. Brenner S, Krakowski A, Levtov O, Heldenberg D, Werbin B, Tamir I. Serum lipids in patients with psoriasis. Dermatologica 1975; 150(2):96-102.
4. Lindegård B. Diseases associated with psoriasis in a general population of 159200 middle aged, urban, native Swedes. Dermatologica 1986; 172(6):298-304.
5. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative stress and its role in skin disease. Antioxid Redox Signal 2002; 4(4):665-73.
6. Binazzi M, Calandra P, Lisi P. Statistical association between psoriasis and diabetes: further results. Arch Dermatol Res 1975; 254(1):43-8.
7. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157(1):68-73.
8. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007; 4(2):143-50.
9. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62.
10. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M. Homocysteine lowering with folic acid and vitamins in vascular disease. New Engl J Med 2006; 354(15):1567-77.
11. Langman LJ, Cole DE. Homocysteine: cholesterol of the 90s? Clin Chim Acta 1999; 286(1-2):63-80.
12. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001; 303(1-2):33-9.
13. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007; 190(1):1-9.
14. Marongiu F, Sorano GG, Bibbò C, et al. Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology 1994; 189(1):32-7.
15. Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrex Clin Pharmcaol Ther 1989; 46(5):510-20.
16. Kural BV, Örem A, ÇimKural BV, Örem A, ÇimPlasma homocysteine and its relationship with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332:23-30.
17. Malerba M, Gisondi P, Radaeli A, Sala R, Calzavara Pinton PG, Girolomoni G. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006; 155(6):1165-9.
18. Woźniak A, Drewa G,Krzyzyńska-Maliniowska E, et al. Oxidant-antioxidant balance in patients with psoriasis. Med Sci Monit 2007; 13(1):30-3.
19. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. The inflammatory response in mild and severe psoriasis. Br J Dermatol 2004; 150:917-28.
20. Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009; 47(7):891-905.
21. Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 2003; 17(6):663-9.
22. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative stress and its role in skin disease. Antiox Redox Signal 2002; 4(4):665-73.
23. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 2007; 9(11):1941-58.